Reckitt Benckiser (RB/ LN, BUY, T/P 6900p) finished 2015 strongly with 7% like for like growth in Q4 as all three of full year net revenue, operating profit and adjusted diluted EPS beat market expectations. With 4% to 5% sales expansion currently targeted for 2016, the growth case for Reckitt Benckiser remains firmly in place. In our view, the shares should be bought up to a 26x 2016 P/E – hence our 6900p price target.
15 Feb 2016
Impressive end to 2015 with 7% Q4 sales growth
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Impressive end to 2015 with 7% Q4 sales growth
Reckitt Benckiser Group plc (RKT:LON) | 4,140 1200.6 0.7% | Mkt Cap: 29,259m
- Published:
15 Feb 2016 -
Author:
Chris Wickham -
Pages:
3
Reckitt Benckiser (RB/ LN, BUY, T/P 6900p) finished 2015 strongly with 7% like for like growth in Q4 as all three of full year net revenue, operating profit and adjusted diluted EPS beat market expectations. With 4% to 5% sales expansion currently targeted for 2016, the growth case for Reckitt Benckiser remains firmly in place. In our view, the shares should be bought up to a 26x 2016 P/E – hence our 6900p price target.